You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Hepatitis B

  • Quality standard
  • Reference number: QS65
  • Published:  28 July 2014
  • Quality standard
  • Tools and resources
  • History
Download (PDF)
  • Overview
  • Quality statements
  • Quality statement 1: Testing and vaccination for hepatitis B
  • Quality statement 2: Referral for specialist care
  • Quality statement 3: Referral to and assessment by specialist care for pregnant women who are identified as hepatitis B surface antigen-positive at antenatal screening
  • Quality statement 4: Complete course of neonatal hepatitis B vaccination and blood testing at 12 months
  • Quality statement 5: Personalised care plan
  • Quality statement 6: Monitoring people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment
  • Quality statement 7: 6-monthly surveillance testing for hepatocellular carcinoma in adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis
  • Update information
  • About this quality standard

Update information

Minor changes since publication

May 2022: Changes have been made to align this quality standard with the updated NICE guideline on vaccine uptake in the general population. Links, source guidance references and data sources have been updated throughout.


Next page About this quality standard Previous page Quality statement 7: 6-monthly surveillance testing for hepatocellular carcinoma in adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis